However, plecstatin-1 targets the scaffold protein plectin and is believed to be an indirect ROS-inducer because the interaction of plecstatin-1 with plectin affects cytoskeletal organisation in cancer cells and impacts on mitochondrial distribution (Meier et al., 2017). Here, PLEC is linked to cancer.